GNOM · Global X
Global X Genomics & Biotechnology ETF
See how 51 reported holdings combine into this ETF’s P/E and P/S. Market value, signed ordinary earnings and revenue are added before each ratio is calculated.
Core valuation
Coverage is the share of positive eligible-equity holding value represented in each metric. The published holdings account for 100.00% of fund weight. The reliability standard requires at least 90.00% disclosed fund weight and metric coverage, with no individual uncovered holding above 1.00%.
Largest reported holdings
| Holding | Weight | Trailing P/E | Trailing P/S |
|---|---|---|---|
| GHGUARDANT HEALTH INC COMMON STOCK | 5.43% | -51.72× | 19.82× |
| ILMNILLUMINA INC COMMON STOCK | 4.68% | 48.63× | 8.93× |
| NTRANATERA INC COMMON STOCK | 4.03% | -306.11× | 21.75× |
| BMRNBIOMARIN PHARMACEUTICAL INC COMMON STOCK | 3.97% | 155.02× | 3.32× |
| ARWRARROWHEAD PHARMACEUTICALS IN COMMON STOCK | 3.95% | -28.60× | 13.67× |
| LEGNLEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT | 3.93% | -12.04×* | 3.47×* |
| PRAXPRAXIS PRECISION MEDICINES I COMMON STOCK | 3.89% | -23.62× | Unavailable |
| TWSTTWIST BIOSCIENCE CORP COMMON STOCK | 3.85% | -86.25× | 27.31× |
| VRTXVERTEX PHARMACEUTICALS INC COMMON STOCK | 3.84% | 29.16× | 10.20× |
| CRSPCRISPR THERAPEUTICS AG COMMON STOCK | 3.74% | -11.88× | 400.29× |
Top 10 of 51 reported holdings. * A holding uses its latest full-year result only when both trailing and latest-quarter inputs are unavailable; open the stock for the exact year end.
Most similar funds
Ranked by shared weight across matching disclosed company holdings and explicitly reported same-currency cash.
- ARKG.L · ARK Genomic Revolution UCITS ETF36.49% holdings overlap · London Stock Exchange
- ARKG · ARK Genomic Revolution ETF35.32% holdings overlap · Cboe BZX
- FBT · First Trust NYSE Arca Biotechnology Index Fund30.53% holdings overlap · NYSE Arca
- HELX · Franklin Genomic Advancements ETF29.56% holdings overlap · Cboe BZX
- EKG · First Trust Nasdaq Lux Digital Health Solutions ETF23.95% holdings overlap · Nasdaq
Sources and limitations
Holdings are sourced from Global X and company financial inputs retain primary-source links. Monetary values are normalised to USD. Corporate actions, reporting lags, unmapped securities and cash can create differences from provider figures.
Open official holdings sourceResearch holdings date: 31 May 2026. Informational research, not investment advice.